Ц.Сарнай
Loading...
Товч нэр
Ц.Сарнай
Бүтэн нэр
Цагаанхүү Сарнай
Латин нэр
Tsagaankhuu Sarnai
Албан тушаал
Тэнхимийн эрхлэгч
Багш
Харьяалал
ORCID
Scopus Author ID
Now showing 1 - 2 of 2
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Maternal group B Streptococcus colonization: Correlation between IL-6/IL-15 cytokine profiles and infection biomarkers for early risk prediction(Mongolian National University of Medical Sciences, 2026-03-30) ;Han Wu, Ri Han Wu ;Batu, Baoyin Batu; ; Objective: To investigate the risk factors for adverse pregnancy outcomes in women with late-trimester Group B Streptococcus (GBS) colonization and to evaluate the predictive value of serum C-reactive protein (CRP), procalcitonin (PCT), interleukin-6 (IL-6), and interleukin-15 (IL-15) as biomarkers for these outcomes. Methods: This is a prospective cohort study of 160 women (80 GBS-positive and 80 GBS-negative). Clinical data, serum biomarkers (CRP, PCT, IL-6, IL-15), and vaginal secretion samples were collected. Statistical analyses were performed to identify independent risk factors and to assess the diagnostic accuracy of the biomarkers using receiver operating characteristic (ROC) curves. Results: Independent risk factors for adverse pregnancy outcomes in GBS-colonized women include advanced maternal age, gestational diabetes mellitus, a history of miscarriage, and vaginal dysbiosis. The combined measurement of CRP, PCT, IL-6, and IL-15 showed superior predictive value for adverse pregnancy outcomes (AUC = 0.913; 95% CI, 0.85-0.97) compared to individual markers. GBS-positive women exhibited a higher incidence of co-infections and adverse neonatal outcomes, such as pneumonia and asphyxia. Conclusion: TA combination of inflammatory biomarkers can serve as a strong predictor of adverse pregnancy outcomes in women with late-stage GBS colonization. These findings support incorporating biomarker testing into GBS screening protocols to enhance risk assessment and guide clinical management. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Causal effect of gut Streptococcus abundance on maternal genitourinary infection during pregnancy: a two-sample Mendelian randomization study(Springer Science and Business Media LLC, 2026-05) ;Wu, Rihan ;Batu, Baoyin; ; Jiang, XilingGenitourinary infections (GUIs) during pregnancy are a significant clinical concern linked to maternal morbidity. To investigate the potential causal effect of gut Streptococcus abundance on the risk of maternal genitourinary infection during pregnancy using Mendelian randomization (MR), we performed a two-sample MR analysis using publicly available genome-wide association study (GWAS) summary statistics. Genetic instruments for gut Streptococcus abundance were obtained from the MiBioGen consortium (N = 18,340). Outcome data for maternal genitourinary infection (ICD-10 O23.x) were sourced from the FinnGen consortium (N = 111,731). The inverse-variance weighted (IVW) method was used as the primary analysis, supplemented by sensitivity analyses including MR-Egger, weighted median, and MR-PRESSO to assess pleiotropy. We further assessed potential mediation via systemic inflammation (C-reactive protein, interleukin-6) and associations with adverse pregnancy outcomes (APOs). Genetically predicted higher gut Streptococcus abundance was associated with a reduced risk of maternal genitourinary infection (IVW odds ratio [OR] = 0.63, 95% confidence interval [CI]: 0.43-0.93, p = 0.020). Sensitivity analyses supported this protective association, with no evidence of horizontal pleiotropy (MR-Egger intercept p = 0.942) or significant heterogeneity. No causal effects were observed on systemic inflammatory markers (CRP, IL-6, all p > 0.05) or on major APOs, including postpartum haemorrhage and placental abruption. This MR study provides genetic evidence supporting a causal, protective role of gut Streptococcus against the risk of clinically diagnosed genitourinary infection during pregnancy. This effect appears specific and is not mediated through the systemic inflammatory pathways examined, suggesting a localized mechanism within the genitourinary tract.
